×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [2]
THE STATE KEY LA... [2]
Faculty of Healt... [1]
Faculty of Scien... [1]
Authors
LU JINJIAN [1]
HU HAO [1]
UNG OI LAM CAROL... [1]
Document Type
Other [1]
Review article [1]
Date Issued
2024 [1]
2022 [1]
Language
英語English [2]
Source Publication
Chinese Journal ... [1]
Discover Oncolog... [1]
Indexed By
SCIE [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-2 of 2
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Combination strategies for first-line treatment of patients with unresectable hepatocellular carcinoma: prospect of natural products
Other
2024-01-01
Authors:
ZHANG, Lele
;
LU, Jinjian
Favorite
|
TC[WOS]:
4
TC[Scopus]:
4
|
Submit date:2024/02/22
Combination Strategies
Immunotherapy
Natural Products
Pd-1/pd-l1
Unresectable Hepatocellular Carcinoma
Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and network meta-analysis
Review article
2022
Authors:
Lei, Qing
;
Yan, Xin
;
Zou, Huimin
;
Jiang, Yixuan
;
Lai, Yunfeng
; et al.
Favorite
|
TC[WOS]:
13
TC[Scopus]:
11
IF:
2.8
/
2.8
|
Submit date:2023/01/30
First-line
Immune Checkpoint Inhibitors
Meta-analysis
Network Meta-analysis
Unresectable Hepatocellular Carcinoma